Atrial Fibrillation

Conditions and Treatments

Posts Tagged ‘Cardiology’

Groundbreaking Results in the RE-LY® Trial Novel Oral Dire

Posted September 10th, 2009 by admin | No Comments

Eve Knight, director and co-founder of the charity organisation AntiCoagulation Europe, talks about the huge need for stroke prevention in patients with atrial fibrillation and about the importance of RE-LY.
Duration : 0:0:50

addthis_url = ‘http%3A%2F%2Fwww.matterhealth.net%2Fatrial-fibrillation-stroke%2Fgroundbreaking-results-in-the-re-ly%25c2%25ae-trial-novel-oral-dire-2%2F’;
addthis_title = ‘Groundbreaking+Results+in+the+RE-LY%C2%AE+Trial++Novel+Oral+Dire’;
addthis_pub = ”;

Technorati Tags: Biotechnology, Cardiology, Clinical [...]

Groundbreaking Results in the RE-LY® Trial Novel Oral Dire

Posted September 3rd, 2009 by admin | No Comments

Professor Stuart Connolly, co-principal investigator of the RE-LY study, McMaster University, Hamilton, Canada, explains the results of the RE-LY trial in achieving superior stroke reduction for atrial fibrillation patients.
Duration : 0:0:51

addthis_url = ‘http%3A%2F%2Fwww.matterhealth.net%2Fatrial-fibrillation-stroke%2Fgroundbreaking-results-in-the-re-ly%25c2%25ae-trial-novel-oral-dire%2F’;
addthis_title = ‘Groundbreaking+Results+in+the+RE-LY%C2%AE+Trial++Novel+Oral+Dire’;
addthis_pub = ”;

Technorati Tags: Biotechnology, Cardiology, Clinical Trials, [...]